HY-136247-1mg
|
MedChemexpress LLC
|
Cyanine 5 Tyramide [CAS 1431148-26-3]
|
|
|
|
HY-136247-10mg
|
MedChemexpress LLC
|
Cyanine 5 Tyramide [CAS 1431148-26-3]
|
|
|
|
HY-136247-5mg
|
MedChemexpress LLC
|
Cyanine 5 Tyramide [CAS 1431148-26-3]
|
|
|
|
HY-136247A-1mg
|
MedChemexpress LLC
|
Cyanine 5 Tyramide methyl indole
|
|
|
|
HY-136247A-5mg
|
MedChemexpress LLC
|
Cyanine 5 Tyramide methyl indole
|
|
|
|
HY-147259-10mg
|
MedChemexpress LLC
|
Dalmelitinib [CAS 1637658-98-0]
|
|
Cancer-Kinase/protease
|
|
HY-147259-100mg
|
MedChemexpress LLC
|
Dalmelitinib [CAS 1637658-98-0]
|
|
Cancer-Kinase/protease
|
|
HY-147259-25mg
|
MedChemexpress LLC
|
Dalmelitinib [CAS 1637658-98-0]
|
|
Cancer-Kinase/protease
|
|
HY-147259-5mg
|
MedChemexpress LLC
|
Dalmelitinib [CAS 1637658-98-0]
|
|
Cancer-Kinase/protease
|
|
HY-147259-50mg
|
MedChemexpress LLC
|
Dalmelitinib [CAS 1637658-98-0]
|
|
Cancer-Kinase/protease
|
|
HY-147259-1mL
|
MedChemexpress LLC
|
Dalmelitinib [CAS 1637658-98-0] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-131008-1mg
|
MedChemexpress LLC
|
Fluorescein tyramide [CAS 210236-90-1]
|
|
|
|
HY-131008-10mg
|
MedChemexpress LLC
|
Fluorescein tyramide [CAS 210236-90-1]
|
|
|
|
HY-131008-5mg
|
MedChemexpress LLC
|
Fluorescein tyramide [CAS 210236-90-1]
|
|
|
|
HY-145337-10mg
|
MedChemexpress LLC
|
FT3967385
|
|
Cancer-programmed cell death
|
|
HY-145337-100mg
|
MedChemexpress LLC
|
FT3967385
|
|
Cancer-programmed cell death
|
|
HY-145337-25mg
|
MedChemexpress LLC
|
FT3967385
|
|
Cancer-programmed cell death
|
|
HY-145337-5mg
|
MedChemexpress LLC
|
FT3967385
|
|
Cancer-programmed cell death
|
|
HY-145337-50mg
|
MedChemexpress LLC
|
FT3967385
|
|
Cancer-programmed cell death
|
|